BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST · NASDAQ Global Market
+$0.08 today
Vol 0.00M · Avg 0.03M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.1M +13.8% | -$12.9M -2.8% | -$12.6M -11.8% | -$11.2M -14.3% | -$9.8M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $1.6M +29.8% | $1.3M +48.9% | $840.0K +18.0% | $712.0K +84.7% | $385.6K | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $597.0K -0.7% | $601.0K +6.7% | $563.0K -58.4% | $1.4M -59.8% | $3.4M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$1.9M -249.9% | -$555.0K -173.5% | $755.0K +345.1% | -$308.0K -220.8% | -$96.0K | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$1.1M -86.0% | -$594.0K -2600.0% | -$22.0K +96.3% | -$588.0K -121.1% | -$266.0K | $592.6M | $1.3B | $626.2M |
| Inventory | -$904.0K +24.0% | -$1.2M -9.3% | -$1.1M -141.8% | -$450.0K +45.7% | -$828.0K | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $0 -100.0% | $1.0M | $0 -100.0% | $730.0K | $0 | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $67.0K -64.4% | $188.0K -89.9% | $1.9M | $0 -100.0% | $998.0K | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $3.6M -26.4% | $4.9M +161.8% | $1.9M +688.3% | $239.0K +138.1% | -$627.0K | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | -$7.2M -8.1% | -$6.7M +21.6% | -$8.5M +7.8% | -$9.2M -36.0% | -$6.8M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$2.4M +16.9% | -$2.8M -92.3% | -$1.5M -17.4% | -$1.3M +23.4% | -$1.6M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | -$10.0K +94.8% | -$192.0K | $0 | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$2.4M +21.9% | -$3.0M -105.4% | -$1.5M -17.4% | -$1.3M +23.4% | -$1.6M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $5.2M +157.0% | $2.0M -84.5% | $13.2M +80.2% | $7.3M +2298.5% | -$332.0K | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $25.1M +479.6% | $4.3M +710.6% | $534.2K -39.1% | $877.0K -88.3% | $7.5M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$159.0K -139.0% | $408.0K +411.0% | -$131.2K -245.2% | -$38.0K -101.0% | $3.6M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $30.2M +345.2% | $6.8M -50.0% | $13.6M +66.6% | $8.1M -24.5% | $10.8M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $39.0K +214.7% | -$34.0K -157.6% | $59.0K +368.2% | -$22.0K -450.0% | -$4.0K | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $20.6M +796.0% | -$3.0M -181.9% | $3.6M +252.0% | -$2.4M -202.0% | $2.3M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$9.6M -0.7% | -$9.5M +4.8% | -$10.0M +4.8% | -$10.5M -24.5% | -$8.4M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
TRX Gold Corporation
AMEX:TRX
$296.96M
Friedman Industries, Incorporated
NASDAQ:FRD
$262.09M
Core Molding Technologies, Inc.
AMEX:CMT
$210.43M
FutureFuel Corp.
NYSE:FF
$186.86M
Ascent Industries Co.
NASDAQ:ACNT
$126.04M
U.S. GoldMining Inc.
NASDAQ:USGO
$110.31M
American Vanguard Corporation
NYSE:AVD
$74.66M
Mercer International Inc.
NASDAQ:MERC
$58.21M
Bioceres Crop Solutions Corp.
BIOX
$24.88M
Lavoro Limited
LVRO
$15.06M
SEC Filings
Recent regulatory filings
No filings found.
Does BHST generate free cash flow?
BioHarvest Sciences Inc. Common Stock (BHST) generated -$9,581,000.00 of free cash flow in fiscal 2025.
How much operating cash flow does BHST produce?
Operating cash flow was -$7,226,000.00, before capital expenditures of $2.35M.
Explore More
Continue the stock analysis
Jump to another research area for this company.